The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy

被引:0
|
作者
Lapic, Ivana [1 ]
Vrancic, Ana Loncar [1 ]
Herak, Desiree Coen [1 ]
Rogic, Dunja [1 ]
机构
[1] Univ Hosp Ctr Zagreb, Dept Lab Diagnost, Zagreb, Croatia
关键词
pre-analytical phase; hemostasis; activated partial thromboplastin time; unfractionated heparin; TRANSMITTANCE WAVE-FORM; COAGULATION; HEMOLYSIS; ICTERUS; SEPSIS;
D O I
10.11613/BM.2021.021003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This case report describes false shortening of activated partial thromboplastin time (aPTT) due to erroneous optical reading of the clotting point in the presence of unfractionated heparin (UFH), and a biphasic waveform. Activated partial thromboplastin time performed on a coagulometer with photo-optical detection yielded an ambiguous clotting curve characterized by an early and steady decrease in light transmittance throughout the whole measuring range, with the clotting point read at 65 seconds. Further investigations included measurement of aPTT by means of a mechanical clot detection method as well as determination of another heparin-sensitive coagulation assay, that is thrombin time (TT), both being unmeasurably prolonged (> 150 seconds). Communication with clinicians revealed that the patient was on continuous UFH therapy and had an underlying sepsis, with highly elevated C-reactive protein (289 mg/L). The aPTT measurements requested at three timepoints later during the same day revealed gradual aPTT shortening and unveiled a peculiar biphasic waveform pattern. In this case, unmeasurably prolonged aPTT due to UFH therapy was masked by a biphasic aPTT curve pattern making only the first slope of the biphasic waveform visible within the measuring range. The early decrease in plasma light transmittance mimicked optical changes related to clot formation, thus causing erroneous optical reading and yielding a falsely shortened aPTT. This case emphasizes that such a pattern should be carefully inspected, especially when a combination of a critically ill condition and UFH therapy is present, in order to prevent erroneous reporting of aPTT and potential adverse effects on patient care.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations
    Marlar, Richard A.
    Clement, Bernadette
    Gausman, Jana
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 253 - 260
  • [2] Stability of the activated partial thromboplastin time used to monitor unfractionated heparin
    Ray, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) : 1817 - 1819
  • [3] Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges
    van den Besselaar, AMHP
    Sturk, A
    Reijnierse, GLA
    THROMBOSIS RESEARCH, 2002, 107 (05) : 235 - 240
  • [4] ACTIVATED PARTIAL THROMBOPLASTIN TIME AS A CONTROL IN HEPARIN THERAPY
    HARMELING, JG
    CORDRAY, DR
    SOUTHERN MEDICAL JOURNAL, 1967, 60 (06) : 594 - +
  • [5] MONITORING HEPARIN THERAPY WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME
    STUART, RK
    MICHEL, A
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1971, 104 (05) : 385 - &
  • [6] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy
    Pearlman, Eugene
    Bibars, Wafi
    Willard, Jennifer
    Moore, Darlene
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A127 - A127
  • [7] Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation
    Thompson, Molly H.
    Wilson, Sylvia H.
    Toussaint, Brittany L.
    Jordan, Cameron L.
    Hayes, Genevieve L.
    McKinzie, Brian P.
    Wolf, Bethany J.
    Field, Larry C.
    JOURNAL OF CLINICAL ANESTHESIA, 2016, 33 : 346 - 350
  • [8] Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin
    Gouin-Thibault, Isabelle
    Samama, Michel M.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (05) : 986 - 987
  • [9] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558
  • [10] Activated Partial Thromboplastin Time Elevation After Low-Dose Unfractionated Heparin
    Pirouz, R.
    Smith, P. R.
    Vaynkof, Y.
    Balakrishna, S.
    Chand, R.
    Atluri, S.
    Gerolemou, L.
    Elias, M.
    Mir, S.
    Nishimoto, T.
    Surapaneni, P.
    Jimenez, E.
    O'Neill, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187